IMP
Process View
pressure natriuresis
The process in which the volume of blood increases renal pressure and thereby results in both an increase in urine volume (diuresis) and an increase in the amount of sodium excreted in the urine (natriuresis).
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "pressure natriuresis"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| CYP4F2 | cytochrome P450, family 4, subfamily F, polypeptide 2 | 0.982 | ||
| CYP4F3 | cytochrome P450, family 4, subfamily F, polypeptide 3 | 0.576 | Human | |
| CYP4F12 | cytochrome P450, family 4, subfamily F, polypeptide 12 | 0.272 | Human | |
| CYP4F11 | cytochrome P450, family 4, subfamily F, polypeptide 11 | 0.265 | Human | |
| CYP2C9 | cytochrome P450, family 2, subfamily C, polypeptide 9 | 0.093 | ||
| CYP2B6 | cytochrome P450, family 2, subfamily B, polypeptide 6 | 0.091 | ||
| DAO | D-amino-acid oxidase | 0.090 | ||
| CYP3A43 | cytochrome P450, family 3, subfamily A, polypeptide 43 | 0.078 | ||
| CYP3A4 | cytochrome P450, family 3, subfamily A, polypeptide 4 | 0.072 | ||
| FABP1 | fatty acid binding protein 1, liver | 0.069 | ||
| KNG1 | kininogen 1 | 0.060 | ||
| CYP3A5 | cytochrome P450, family 3, subfamily A, polypeptide 5 | 0.054 | ||
| AKR1C4 | aldo-keto reductase family 1, member C4 (chlordecone reductase; 3-alpha hydroxysteroid dehydrogenase, type I; dihydrodiol dehydrogenase 4) | 0.050 | ||
| OTC | ornithine carbamoyltransferase | 0.040 | ||
| UGT1A3 | UDP glucuronosyltransferase 1 family, polypeptide A3 | 0.039 | ||
| AZGP1 | alpha-2-glycoprotein 1, zinc-binding | 0.035 | ||
| HAL | histidine ammonia-lyase | 0.033 | ||
| G6PC | glucose-6-phosphatase, catalytic subunit | 0.032 | ||
| CYP3A7 | cytochrome P450, family 3, subfamily A, polypeptide 7 | 0.031 | ||
| CYP2C8 | cytochrome P450, family 2, subfamily C, polypeptide 8 | 0.029 | ||
| SULT1B1 | sulfotransferase family, cytosolic, 1B, member 1 | 0.027 | ||
| C6 | complement component 6 | 0.025 | ||
| ADH6 | alcohol dehydrogenase 6 (class V) | 0.025 | ||
| SULT1E1 | sulfotransferase family 1E, estrogen-preferring, member 1 | 0.024 | ||
| GSTA3 | glutathione S-transferase alpha 3 | 0.023 | ||
| SULT2A1 | sulfotransferase family, cytosolic, 2A, dehydroepiandrosterone (DHEA)-preferring, member 1 | 0.023 | ||
| APOC3 | apolipoprotein C-III | 0.023 | ||
| ABCC2 | ATP-binding cassette, sub-family C (CFTR/MRP), member 2 | 0.022 | ||
| CYP4A11 | cytochrome P450, family 4, subfamily A, polypeptide 11 | 0.022 | ||
| HMGCS2 | 3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial) | 0.021 | ||
| PKLR | pyruvate kinase, liver and RBC | 0.021 | ||
| RDH16 | retinol dehydrogenase 16 (all-trans) | 0.020 | ||
| CYP4F8 | cytochrome P450, family 4, subfamily F, polypeptide 8 | 0.019 | Human | |
| CYP2C18 | cytochrome P450, family 2, subfamily C, polypeptide 18 | 0.019 | ||
| SLC25A47 | solute carrier family 25, member 47 | 0.018 | ||
| CYP4B1 | cytochrome P450, family 4, subfamily B, polypeptide 1 | 0.017 | Human | |
| DIO1 | deiodinase, iodothyronine, type I | 0.016 | ||
| ADRA1A | adrenergic, alpha-1A-, receptor | 0.016 | ||
| EPHX2 | epoxide hydrolase 2, cytoplasmic | 0.016 | ||
| ARG1 | arginase, liver | 0.015 | ||
| KRT13 | keratin 13 | 0.015 | ||
| PLG | plasminogen | 0.015 | ||
| CYP2C19 | cytochrome P450, family 2, subfamily C, polypeptide 19 | 0.015 | ||
| LIPC | lipase, hepatic | 0.014 | ||
| PAH | phenylalanine hydroxylase | 0.014 | ||
| DEFB1 | defensin, beta 1 | 0.014 | ||
| CYP2E1 | cytochrome P450, family 2, subfamily E, polypeptide 1 | 0.014 | ||
| SULT2B1 | sulfotransferase family, cytosolic, 2B, member 1 | 0.013 | ||
| TMPRSS4 | transmembrane protease, serine 4 | 0.013 | ||
| C9 | complement component 9 | 0.013 | ||
| C4BPA | complement component 4 binding protein, alpha | 0.013 | ||
| APOF | apolipoprotein F | 0.013 | ||
| SCNN1B | sodium channel, nonvoltage-gated 1, beta | 0.012 | ||
| SEC14L2 | SEC14-like 2 (S. cerevisiae) | 0.012 | ||
| ORM1 | orosomucoid 1 | 0.012 | ||
| MAT1A | methionine adenosyltransferase I, alpha | 0.012 | ||
| FABP2 | fatty acid binding protein 2, intestinal | 0.012 | ||
| BHMT | betaine--homocysteine S-methyltransferase | 0.011 | ||
| SLC22A1 | solute carrier family 22 (organic cation transporter), member 1 | 0.011 | ||
| PIPOX | pipecolic acid oxidase | 0.011 | ||
| F13B | coagulation factor XIII, B polypeptide | 0.011 | ||
| PIP | prolactin-induced protein | 0.011 | ||
| NAT8 | N-acetyltransferase 8 (GCN5-related, putative) | 0.011 | ||
| PCK1 | phosphoenolpyruvate carboxykinase 1 (soluble) | 0.011 | ||
| CRP | C-reactive protein, pentraxin-related | 0.011 | ||
| KLKB1 | kallikrein B, plasma (Fletcher factor) 1 | 0.011 | ||
| SCNN1A | sodium channel, nonvoltage-gated 1 alpha | 0.011 | ||
| GSTT1 | glutathione S-transferase theta 1 | 0.010 | ||
| HGD | homogentisate 1,2-dioxygenase | 0.010 | ||
| CRISP3 | cysteine-rich secretory protein 3 | 0.010 | ||
| ADH1C | alcohol dehydrogenase 1C (class I), gamma polypeptide | 0.010 | ||
| SCGB2A1 | secretoglobin, family 2A, member 1 | 0.010 | ||
| FLG | filaggrin | 0.010 | ||
| ABCB11 | ATP-binding cassette, sub-family B (MDR/TAP), member 11 | 0.010 | ||
| BAAT | bile acid CoA: amino acid N-acyltransferase (glycine N-choloyltransferase) | 0.010 |